close
Add to watchlist
Amarin ADR (AMRN) Healthcare
Amarin Corporation plc operates as a clinical-stage biopharmaceutical company. The company has a lead program planned to enter Phase III for hypertriglyceridemia. Its cardiovascular programs focus in the field of lipid science and the known therapeutic benefits of essential fatty acids in cardiovascular disease. The company's pipeline also includes programs in myasthenia gravis, Huntington's disease, Parkinson's disease, and epilepsy. Amarin Corporation plc, formerly known as Ethical Holdings plc, was founded in 1989 and is based in Dublin, Ireland.
(login to add this stock to your watchlist or favorites)
Key Statistics
| Closing Price | 8.02 |
| Volume | (mio) 11.58 |
| Volume Avg | (mio) 2.88 |
| 52 Week High | 19.87 |
| 52 Week Low | 5.99 |
| PE | N/A |
| PE (group average) | 39 |
| EPS Year | -0.53 |
| EPS change Q/Q | -1000% |
| EPS change Q/Q Yr ago | -1000% |
| EPS change Q/Q next Q est | -1000% |
| EPS change Y/Y | -40% |
| REV change Q/Q | 0% |
| REV change Q/Q Yr ago | 0% |
| EPS next Q est | -0.05 |
| EPS next Y est | 0.34 |
| Divident Annual | 0.00 |
| Dividend Yield | 0% |